Position in ANIP
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,199,640
+$433,922 QoQ
Shares Held
15,600
+60.8% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Polaris Capital Management, LLC holds $107,320,546 across 5 Drug Manufacturers - Specialty & Generic names. ANIP ranks #3 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
96,650 | $57,311,517 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
617,000 | $46,799,450 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
This page
|
15,600 | $1,199,640 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
22,500 | $1,163,025 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
43,232 | $846,914 |
All Filings in ANIP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,199,640 | 15,600 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $765,718 | 9,700 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $888,520 | 9,700 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||